1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinical behavior of endometrioid and serous endometrial carcinomas is governed by distinct biological processes
    Meeting Abstract

    Weigelt, B.; Lemetre, C.; Ng, C. K. Y.; Piscuoglio, S.; Reis, J. S.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dystrophin is a tumor suppressor in human cancers with myogenic programs
    Meeting Abstract

    Wang, Y. X.; Marino-Enriquez, A.; Bennett, R.; Zhu, M. J.; Eilers, G.; Antonescu, C.; Fletche, C.; Raut, C.; van de Rijn, M.; Kunkel, L.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A genome-wide association study suggests evidence of variants at 6p21.32 associated with marginal zone lymphoma
    Meeting Abstract

    Vijai, J.; Wang, Z. M.; Berndt, S. I.; Slager, S. L.; Cerhan, J. R.; Skibola, C.; Wang, S. S.; Brooks-Wilson, A. R.; De Sanjose, S.; Bracci, P. M.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Harmonization of next generation sequencing data within consortia for gene discovery in familial breast cancer
    Meeting Abstract

    Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Guidugli, L.; Schrader, K.; Maxwell, K.; Jacobs, L.; Villano, D.; Klein, R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Competition between tumor cells by entosis
    Meeting Abstract

    Sun, Q.; Luo, T. Z.; Ren, Y. X.; Florey, O.; Cibas, E. S.; Hodgson, L.; Robinson, D. N.; Overholtzer, M.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Stein, E.; Tallman, M.; Pollyea, D. A.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; Levine, R. L.; Agresta, S.; Schenkein, D.; Yang, H.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Application of a multiplexed fluorescence microscopy method (MultiOmyx (TM)) to dissect proteomic biomarkers of (18)F-fluorodeoxy-glucose ((18)FDG) uptake in breast cancer
    Meeting Abstract

    Sood, A.; Miller, A. M.; Ginty, F.; McDonough, E.; Sui, Y. X.; Bordwell, A.; Li, Q.; Kaanumalle, S.; Pang, Z. Y.; Torres, F.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
    Meeting Abstract

    Silber, J.; Harinath, G.; Parthasarathy, P. T.; Fabius, A. W. M.; Turcan, S.; Chan, T. A.; Huse, J. T.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
    Meeting Abstract

    Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Determination of cancer susceptibility in probands with breast and ovarian cancer
    Meeting Abstract

    Schrader, K. A.; Maxwell, K. N.; Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Guidugli, L.; Klein, R.; Corines, M.; Zhang, L.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save